BioCentury | Aug 11, 2016
Financial News

Metabolon raises $15M in series E

...declined to comment on its plans for repurchasing shares. Metabolon's prior investors include Camden Partners, Sumitomo Corp. Group...
BioCentury | Sep 5, 2011
Company News

Astellas, Sumitomo Corp. Group deal

...is expected to close mid-September. Terms were not disclosed. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Sumitomo Corp. Group...
BioCentury | Jun 13, 2011
Company News

Neuralstem, Sumitomo Corp. Group deal

...Phase I testing for major depression. Terms were not disclosed. Neuralstem Inc. (NYSE-A:CUR), Rockville, Md. Sumitomo Corp. Group...
Items per page:
1 - 3 of 3
BioCentury | Aug 11, 2016
Financial News

Metabolon raises $15M in series E

...declined to comment on its plans for repurchasing shares. Metabolon's prior investors include Camden Partners, Sumitomo Corp. Group...
BioCentury | Sep 5, 2011
Company News

Astellas, Sumitomo Corp. Group deal

...is expected to close mid-September. Terms were not disclosed. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Sumitomo Corp. Group...
BioCentury | Jun 13, 2011
Company News

Neuralstem, Sumitomo Corp. Group deal

...Phase I testing for major depression. Terms were not disclosed. Neuralstem Inc. (NYSE-A:CUR), Rockville, Md. Sumitomo Corp. Group...
Items per page:
1 - 3 of 3